New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 17, 2014
06:39 EDTICPTIntercept trial deaths unlikely associated with treatment, says Wedbush
Wedush believes the two deaths that occurred during the FLINT Phase 2b trial disclosed late Friday by Intercept are unlikely related to the OCA treatment. The firm says any continued weakness in shares of Intercept would be a buying opportunity and keeps an Outperform rating on the name with a $493 price target.
News For ICPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 1, 2015
07:33 EDTICPTIntercept management to meet with Deutsche Bank
Subscribe for More Information
April 23, 2015
05:44 EDTICPTIntercept FLINT trial data shows OCA treatment increases fibrosis resolution
Subscribe for More Information
April 22, 2015
07:07 EDTICPTEuropean Association for the Study of the Liver to hold annual meeting
50th Annual Meeting of EASL will be held in Vienna, Austria on April 22-26.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use